Edition:
United Kingdom

Citius Pharmaceuticals Inc (CTXR.OQ)

CTXR.OQ on NASDAQ Stock Exchange Capital Market

1.77USD
21 Sep 2018
Change (% chg)

$0.18 (+11.32%)
Prev Close
$1.59
Open
$1.56
Day's High
$1.77
Day's Low
$1.55
Volume
43,984
Avg. Vol
27,204
52-wk High
$5.46
52-wk Low
$1.12

Latest Key Developments (Source: Significant Developments)

Myron Holubiak Reports 12.6 Pct Stake In Citius Pharmaceuticals
Monday, 27 Aug 2018 

Aug 27 (Reuters) - Myron Z Holubiak::MYRON Z HOLUBIAK REPORTS 12.6 PERCENT STAKE IN CITIUS PHARMACEUTICALS AS OF AUGUST 13 - SEC FILING.MYRON Z HOLUBIAK SAYS OBTAINED SHARES OF COMMON STOCK, WARRANTS TO BUY COMMON STOCK OF CITIUS PHARMACEUTICALS FOR 'INVESTMENT PURPOSES'.  Full Article

Citius Pharmaceuticals Successfully Raises $10 Million
Wednesday, 15 Aug 2018 

Aug 15 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS SUCCESSFULLY RAISES $10 MILLION.CITIUS PHARMACEUTICALS - INTENDS TO USE CAPITAL FROM RAISE TOWARDS PHASE 3 CLINICAL MINO-LOK TRIAL FOR TREATING CATHETER RELATED BLOODSTREAM INFECTIONS.CITIUS PHARMACEUTICALS - INTENDS TO USE CAPITAL FROM RAISE TOWARDS PHASE 2B CLINICAL TRIAL OF CITI-002 FOR SYMPTOMATIC TREATMENT OF HEMORRHOIDS.  Full Article

Citius Pharmaceuticals To Sell Up To 1.4 Mln Shares Of Co's Common Stock
Friday, 20 Apr 2018 

April 20 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS - TO SELL OR OTHER DISPOSITION FROM TIME TO TIME OF UP TO 1.4 MILLION SHARES OF CO'S COMMON STOCK.  Full Article

Citius Announces $6 Mln Registered Direct Offering Priced At-The-Market
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET.CITIUS PHARMACEUTICALS - ENTERED AGREEMENTS WITH SEVERAL INSTITUTIONAL, ACCREDITED INVESTORS TO BUY 1.3 MILLION SHARES AT $4.6925/SHARE.  Full Article

Citius Pharmaceuticals Says On Nov 27, Board Appointed Jaime Bartushak As CFO And Principal Financial Officer Of Co
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Citius Pharmaceuticals Inc ::CITIUS PHARMACEUTICALS INC - ‍ON NOV 27, , BOARD APPOINTED JAIME BARTUSHAK AS CFO AND PRINCIPAL FINANCIAL OFFICER OF COMPANY, EFFECTIVE NOV. 27, 2017​.  Full Article

Citius Pharmaceuticals files for mixed shelf offering of up to $50 mln - SEC filing‍​
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Citius Pharmaceuticals Inc :Citius Pharmaceuticals Inc - files for mixed shelf offering of up to $50 million - SEC filing‍​.  Full Article

Citius pharmaceuticals receives "fast track" designation by FDA for mino-lok™ investigational trial
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Citius Pharmaceuticals Inc :Citius Pharmaceuticals, Inc. Receives "fast track" designation by FDA for mino-lok™ investigational trial.  Full Article

BRIEF-Citius Pharmaceuticals To Sell Up To 1.4 Mln Shares Of Co's Common Stock

* CITIUS PHARMACEUTICALS - TO SELL OR OTHER DISPOSITION FROM TIME TO TIME OF UP TO 1.4 MILLION SHARES OF CO'S COMMON STOCK Source : https://bit.ly/2JdehV7 Further company coverage: (Reuters.Briefs@thomsonreuters.com)